Intervensi Nutrisi Neuroprotektif terhadap Kadar GFAP dan  Skor NIHSS pada Pasien Stroke Iskemik

Diah Retno Wahyuningrum; Kalasta Ayunda Putri; Fitni Hidayati; Fathia Rahmadini

doi:10.55606/jurrike.v4i2.6053

Authors

Diah Retno Wahyuningrum Universitas Negeri Medan
Kalasta Ayunda Putri Universitas Negeri Medan
Fitni Hidayati Universitas Negeri Medan
Fathia Rahmadini Universitas Negeri Medan

DOI:

https://doi.org/10.55606/jurrike.v4i2.6053

Keywords:

GFAP, Ischemic Stroke, Neuroprotective Nutrition, NIHSS, Rehabilitation

Abstract

Stroke is one of the leading causes of disability and mortality worldwide, with significant neurological and biochemical consequences. This study aimed to examine the effect of a neuroprotective nutritional intervention consisting of protein, phosphatidylcholine, phosphatidylserine, and inulin on glial fibrillary acidic protein (GFAP) levels and National Institutes of Health Stroke Scale (NIHSS) scores in acute ischemic stroke patients. The study employed a quasi-experimental design with a pretest-posttest control group, involving 18 patients divided equally into intervention and control groups. Data were collected at Dr. Kariadi General Hospital Semarang from January to February 2020, measuring serum GFAP levels using ELISA and assessing NIHSS scores before and after a seven-day intervention. The intervention group showed a significant decrease in GFAP levels and a more pronounced improvement in NIHSS scores compared to the control group. These findings suggest that the neuroprotective nutritional intervention may support both biochemical and clinical recovery in acute ischemic stroke patients. Implementing such nutritional strategies could complement standard care and enhance rehabilitation outcomes. Further research with larger sample sizes and longer follow-up is recommended to confirm these results and optimize the intervention protocol.

Downloads

Download data is not yet available.

References

Broussalis, E., Trinka, E., Hainfellner, J., & Killer, M. (2020). The NIH Stroke Scale: An updated systematic review. Frontiers in Neurology, 11, 597. https://doi.org/10.3389/fneur.2020.00597

Campbell, B. C. V., & Khatri, P. (2020). Stroke. The Lancet, 396(10244), 129–142. https://doi.org/10.1016/S0140-6736(20)31179-X

Cryan, J. F., O’Riordan, K. J., Sandhu, K., Peterson, V., & Dinan, T. G. (2022). The gut microbiome in neurological disorders. The Lancet Neurology, 21(1), 40–55. https://doi.org/10.1016/S1474-4422(21)00213-4

Feigin, V. L., Stark, B. A., Johnson, C. O., et al. (2021). Global burden of stroke and risk factors in 204 countries and territories, 1990–2019: A systematic analysis. The Lancet Neurology, 20(10), 795–820. https://doi.org/10.1016/S1474-4422(21)00252-0

GBD 2019 Stroke Collaborators. (2021). Global, regional, and national burden of stroke and its risk factors, 1990–2019: A systematic analysis. The Lancet Neurology, 20(10), 795–820. https://doi.org/10.1016/S1474-4422(21)00252-0

Griffin, J. W., Bradshaw, P. C., & Barnes, J. (2019). Phosphatidylserine and cognitive function. Nutrients, 11(8), 1791. https://doi.org/10.3390/nu11081791

Mattila, O. S., Ashton, N. J., Blennow, K., et al. (2021). Serum GFAP and outcome after ischemic stroke: A prospective observational study. Stroke, 52(9), 2925–2933. https://doi.org/10.1161/STROKEAHA.120.033866

Ochoa, J. B., Magnuson, B., Gottesman, R., & Christopher, K. (2020). Nutrition therapy in critical illness: A review of evidence-based guidelines. Current Opinion in Critical Care, 26(4), 334–340. https://doi.org/10.1097/MCC.0000000000000733

Petzold, A., Keir, G., & Green, A. J. (2019). Glial fibrillary acidic protein is an early marker of axonal injury even when axonal transport is intact. Journal of Neurology, Neurosurgery & Psychiatry, 90(1), 18–25. https://doi.org/10.1136/jnnp-2018-318571

Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020). The role of short-chain fatty acids from gut microbiota in gut-brain communication. Frontiers in Endocrinology, 11, 25. https://doi.org/10.3389/fendo.2020.00025

Tykhomyrov, A. A., Bondarenko, O. S., & Sagach, V. F. (2020). Citicoline as a neuroprotector in stroke. Neuroscience and Behavioral Physiology, 50(5), 588–596. https://doi.org/10.1007/s11055-020-00956-0